NA
SANA icon

NewEdge Advisors’s Sana Biotechnology SANA Stock Holding History

NewEdge Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.1K Sell
24,370
-23,050
-49% -$74.3K ﹤0.01% 2985
2026
Q1 		$137K Sell
47,420
-16,979
-26% -$66.9K ﹤0.01% 2685
2025
Q4 		$262K Sell
64,399
-33,231
-34% -$149K ﹤0.01% 2404
2025
Q3 		$347K Buy
97,630
+63,000
+182% +$228K ﹤0.01% 2074
2025
Q2 		$94.5K Buy
34,630
+34,330
+11,443% +$70.8K ﹤0.01% 2440
2025
Q1 		$504 Buy
+300
New +$839 ﹤0.01% 3712

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

NewEdge Advisors's SANA Position: Q2 2026 in Review

NewEdge Advisors reduced its Sana Biotechnology (SANA) stake by 49% in Q2 2026, selling an estimated $74.3K and leaving 24,370 shares worth $85.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2985.

NewEdge Advisors first reported a position in SANA in Q1 2025 and has held it in 6 quarters since. The position peaked at $347K in Q3 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • NewEdge Advisors held 24,370 shares of Sana Biotechnology worth $85.1K as of Q2 2026.
  • NewEdge Advisors sold 23,050 Sana Biotechnology shares in Q2 2026, an estimated $74.3K.
  • Sana Biotechnology made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2985 holding.
  • NewEdge Advisors first reported a position in Sana Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • NewEdge Advisors's Sana Biotechnology position peaked at $347K in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.